Delivery Order SPE2DR25D3016-SPE2DR26FG2ET
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,498.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a $4,229.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $9,618.63 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit-dose packaging. The contract, executed on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,511.26 to AmerisourceBergen Drug Corp on October 31, 2025, under a firm fixed-price contract for pharmaceutical products and medical supplies. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,873.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 14, 2025, with a completion date of November 17, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,814.51 to AmerisourceBergen Drug Corp on November 14, 2025, for pharmaceutical products and medical supplies. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $75,317.59 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed price delivery order, issued on November 18, 2025, with an ultimate completion date of November 18, 2025, represents a non-competitive award to the prime contractor and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child award under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $135,070.25 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,111.98 to AmerisourceBergen Drug Corp on December 17, 2025, under contract 4570309532 for pharmaceutical products and medical supplies. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be completed by December 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2ETDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 125-80-80 mg pharmaceutical packs, valued at $1,226.10, with completion targeted for December 16, 2025. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor providing comprehensive medical supply solutions to military and veteran healthcare systems. This delivery order falls under the company's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling supply of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/14/25 |